🇺🇸 FDA
Patent

US 6518259

Compositions for treating autoimmune disease

expired A61KA61K31/13A61K31/131

Quick answer

US patent 6518259 (Compositions for treating autoimmune disease) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/13, A61K31/131, A61K31/14, A61K31/352